EUVIMEDEUVIMED entdecken
Crossref

Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures

Ivan Milenkovic, Sonia Cruciani, Laia Llovera, Morghan C Lucas, Rebeca Medina, Cornelius Pauli, Daniel Heid, Thomas Muley, Marc A Schneider, Laura V Klotz, Michael Allgäuer, Ruben Lattuca und 3 weitere

Molecular Cell · 2025-01 · 85 (1) · 177-190.e7

DOI: 10.1016/j.molcel.2024.11.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2025-01. Verfasst von Ivan Milenkovic und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain; Universitat Pompeu F…. Hauptthemen laut MEDLINE: RNA, Ribosomal, Lung Neoplasms, Transcriptome. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: European Cooperation in Science and Technology, Deutsches Zentrum für Lungenforschung, H2020 Marie Skłodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mammalian ribosomal RNA (rRNA) molecules are highly abundant RNAs, decorated with over 220 rRNA modifications. Previous works have shown that some rRNA modification types can be dynamically regulated; however, how and when the mammalian rRNA modification landscape is remodeled remains largely unexplored. Here, we employ direct RNA sequencing to chart the human and mouse rRNA epitranscriptome across tissues, developmental stages, cell types, and disease. Our analyses reveal multiple rRNA sites that are differentially modified in a tissue- and/or developmental stage-specific manner, including previously unannotated modified sites. We demonstrate that rRNA modification patterns can be used for tissue and cell-type identification, which we hereby term "epitranscriptomic fingerprinting." We then explore rRNA modification patterns in normal-tumor matched samples from lung cancer patients, finding that epitranscriptomic fingerprinting accurately classifies clinical samples into normal and tumor groups from only 250 reads per sample, demonstrating the potential of rRNA modifications as diagnostic biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, RibosomalLung NeoplasmsTranscriptomeHumansAnimalsMiceRNA Processing, Post-TranscriptionalEpigenesis, GeneticOrgan SpecificityGene Expression Regulation, NeoplasticSequence Analysis, RNA

Stichwörter der Autor:innen

RNA modificationscancerclassificationdirect RNA sequencingepitranscriptomefingerprintingnanoporepseudouridinerRNA

Substanzen

RNA, Ribosomal

Autor:innen und Institutionen

  • Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain; Universitat Pompeu Fabra (UPF), Barcelona 08003, Spain.
  • Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain.
  • Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg 69120, Germany; Molecular Medicine Partnership Unit (MMPU), European Molecular Biology Laboratory (EMBL), Heidelberg 69117, Germany; Division…
  • Translational Lung Research Center (TLRC-H), German Center for Lung Research (DZL), Heidelberg 69120, Germany; Translational Research Unit and Lung Biobank Heidelberg, Thoraxklinik at Heidelberg University Hospital, Hei…
  • Department of Surgery, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
  • Institute of Pathology, Heidelberg University Hospital, Heidelberg 69120, Germany.

Förderung

  • European Cooperation in Science and Technology
  • Deutsches Zentrum für Lungenforschung
  • H2020 Marie Skłodowska-Curie Actions
  • Horizon 2020 Framework Programme
  • European Molecular Biology Organization
  • Fonds De La Recherche Scientifique - FNRS
  • Ministerio de Economía y Competitividad
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Milenkovic, I., Cruciani, S., Llovera, L., Lucas, M. C., Medina, R., Pauli, C., Heid, D., Muley, T., Schneider, M. A., Klotz, L. V., Allgäuer, M., Lattuca, R., Lafontaine, D. L. J., Müller-Tidow, C., & Novoa, E. M. (2025). Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures. Molecular Cell, 85(1), 177-190.e7. https://doi.org/10.1016/j.molcel.2024.11.014

Vancouver

Milenkovic I, Cruciani S, Llovera L, Lucas MC, Medina R, Pauli C, et al. Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures. Molecular Cell. 2025;85(1):177-190.e7. doi:10.1016/j.molcel.2024.11.014

BibTeX
@article{Milenkovic2025,
  author = {Milenkovic, Ivan and Cruciani, Sonia and Llovera, Laia and Lucas, Morghan C and Medina, Rebeca and Pauli, Cornelius and Heid, Daniel and Muley, Thomas and Schneider, Marc A and Klotz, Laura V and Allgäuer, Michael and Lattuca, Ruben and Lafontaine, Denis L J and Müller-Tidow, Carsten and Novoa, Eva Maria},
  title = {Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures},
  journal = {Molecular Cell},
  year = {2025},
  volume = {85},
  number = {1},
  pages = {177--190.e7},
  doi = {10.1016/j.molcel.2024.11.014}
}
Kostenlos starten →